Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials nationally

1

Recruiting in Ohio

1

Cities with sites

Cities in Ohio

Cleveland 1

Recruiting trials in Ohio

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
NCT07140900 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Ohio: Cleveland

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.